GlobalData on MSN6d
Entrada gets UK MHRA authorisation to begin Phase I/II trial of DMD treatment
Entrada Therapeutics has secured authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to ...
marketinference6d
Entrada Therapeutics Initiates Phase 1/2 Study for Duchenne Muscular Dystrophy
The Elevate-44-201 study is a global, two-part, randomized, double-blind placebo-controlled phase 1/2 study evaluating the ...
Medscape5d
Clinical Aspects of Marburg Hemorrhagic Fever
Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates ...